Evidence map›Paper›PMID 30263884›Full record

ArticlePneumonia (Nathan Qld.)2018

Decreased relative risk of pneumococcal pneumonia during the last decade, a nested case-control study.

Carlos M Luna, Laura Pulido, Michael S Niederman, Alberto Casey, Diego Burgos, Sebastián D Leiva Agüero, Alejandra Grosso, Evangelina Membriani, Andrea C Entrocassi, Marcelo Rodríquez Fermepin and 3 more

Open access · goldAbstract read
In one paragraph

Article in Pneumonia (Nathan Qld.), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.6field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 10 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 2 countries.

Carlos M Luna1Department of Medicine, Pulmonary Diseases Division; Hospital de Clínicas, Universidad de Buenos Aires, Ayacucho, 1850, piso 5 dto B, 1112 Buenos Aires, Argentina.
Laura Pulido1Department of Medicine, Pulmonary Diseases Division; Hospital de Clínicas, Universidad de Buenos Aires, Ayacucho, 1850, piso 5 dto B, 1112 Buenos Aires, Argentina.
Michael S Niederman4Pulmonary and Critical Care, New York Presbyterian/ Weill Cornell Medical Center, New York, USA.
Alberto Casey1Department of Medicine, Pulmonary Diseases Division; Hospital de Clínicas, Universidad de Buenos Aires, Ayacucho, 1850, piso 5 dto B, 1112 Buenos Aires, Argentina.
Diego Burgos1Department of Medicine, Pulmonary Diseases Division; Hospital de Clínicas, Universidad de Buenos Aires, Ayacucho, 1850, piso 5 dto B, 1112 Buenos Aires, Argentina.
Sebastián D Leiva Agüero1Department of Medicine, Pulmonary Diseases Division; Hospital de Clínicas, Universidad de Buenos Aires, Ayacucho, 1850, piso 5 dto B, 1112 Buenos Aires, Argentina.
Alejandra Grosso1Department of Medicine, Pulmonary Diseases Division; Hospital de Clínicas, Universidad de Buenos Aires, Ayacucho, 1850, piso 5 dto B, 1112 Buenos Aires, Argentina.
Evangelina Membriani1Department of Medicine, Pulmonary Diseases Division; Hospital de Clínicas, Universidad de Buenos Aires, Ayacucho, 1850, piso 5 dto B, 1112 Buenos Aires, Argentina.
Andrea C Entrocassi1Department of Medicine, Pulmonary Diseases Division; Hospital de Clínicas, Universidad de Buenos Aires, Ayacucho, 1850, piso 5 dto B, 1112 Buenos Aires, Argentina.
Marcelo Rodríquez Fermepin2Department of Chemical Biochemistry, Immuno-Serology Section, Faculty of Pharmacy and Biochemistry; Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina.
Carlos A Vay3Department of Chemical Biochemistry, Section Microbiology, Faculty of Pharmacy and Biochemistry; Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina.
Susana Garcia3Department of Chemical Biochemistry, Section Microbiology, Faculty of Pharmacy and Biochemistry; Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina.
Angela Famiglietti3Department of Chemical Biochemistry, Section Microbiology, Faculty of Pharmacy and Biochemistry; Hospital de Clínicas, Universidad de Buenos Aires, Buenos Aires, Argentina.
University of Buenos Aires · ARHospital de Clínicas "José de San Martín" · ARPulmonary Associates · USPresbyterian Hospital · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background

methodsThis was a matched nested case-control study of two prospectively recorded cohorts of patients admitted with CAP, with SPUAT and blood culture performed in all patients. CAP2 cases and CAP1 controls were matched for age ± 4 years, sex, and Pneumonia Severity Index (PSI) score ± 10 points. Odds ratios (OR) for having SPUAT positive was estimated by conditional logistic regression. A multivariate model assessed the contribution of individual variables.

resultsFour hundred ninety-eight patients were recruited; 307 during the CAP1 and 191 during the CAP2 periods. Comparing both periods we observed differences, in age, PSI score, and the percentage of smokers, outpatients, previously immunized with pneumococcal vaccine, and positive SPUAT. On the other hand, mortality, admission from nursing homes, pneumococcal bacteremia and hospital admission were not different. After matching, pneumonia due to SP per the SPUAT was observed in 34(23.4%) of CAP1 and in 12(8.3%) of CAP2 patients (

conclusionWe observed a reduction of the role of SP as pathogen, along with an increase in the number of patients who received pneumococcal immunization before admission, in 2015-2016 compared to 2001-2002. In addition, the use of conjugate 13-valent vaccine, starting in 2012 for childhood immunization, could be an additional factor contributing to these changes, as a result of early herd immunity in adults pneumonia.

Indexed as

Community acquired pneumoniaPneumococcal conjugate vaccinePrevalenceStreptococcus pneumoniaeUrinary antigen test

Identifiers

PMID30263884
PMCPMC6154928
OpenAlexW2892347522

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.